November 26th, Goldmam Sachs: Raised the target price of CVS Health from $73 to $80, maintaining a "buy" rating. (Gelong Hui)
高盛上调CVS Health目标价至80美元
Goldman Sachs raises the target price for CVS Health to $80.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.